Literature DB >> 29733453

Indeed, IL-18 is more than an inducer of IFN-γ.

Charles Anthony Dinarello1,2, Gilles Kaplanski3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29733453      PMCID： PMC6290467          DOI： 10.1002/JLB.CE0118-025RR

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN： 0741-5400            Impact factor:   4.962


× No keyword cloud information.
  10 in total

1.  Life-threatening NLRC4-associated hyperinflammation successfully treated with IL-18 inhibition.

Authors:  Scott W Canna; Charlotte Girard; Louise Malle; Adriana de Jesus; Neil Romberg; Judith Kelsen; Lea F Surrey; Pierre Russo; Andrew Sleight; Eduardo Schiffrin; Cem Gabay; Raphaela Goldbach-Mansky; Edward M Behrens
Journal:  J Allergy Clin Immunol       Date:  2016-11-19       Impact factor: 10.793

2.  Severe imbalance of IL-18/IL-18BP in patients with secondary hemophagocytic syndrome.

Authors:  Karin Mazodier; Valérie Marin; Daniela Novick; Catherine Farnarier; Stéphane Robitail; Nicolas Schleinitz; Véronique Veit; Pascale Paul; Menachem Rubinstein; Charles A Dinarello; Jean-Robert Harlé; Gilles Kaplanski
Journal:  Blood       Date:  2005-07-14       Impact factor: 22.113

3.  M-CSF induces the expression of a membrane-bound form of IL-18 in a subset of human monocytes differentiating in vitro toward macrophages.

Authors:  Francesca Bellora; Roberta Castriconi; Andrea Doni; Claudia Cantoni; Lorenzo Moretta; Alberto Mantovani; Alessandro Moretta; Cristina Bottino
Journal:  Eur J Immunol       Date:  2012-06       Impact factor: 5.532

4.  A novel costimulatory factor for gamma interferon induction found in the livers of mice causes endotoxic shock.

Authors:  H Okamura; K Nagata; T Komatsu; T Tanimoto; Y Nukata; F Tanabe; K Akita; K Torigoe; T Okura; S Fukuda
Journal:  Infect Immun       Date:  1995-10       Impact factor: 3.441

5.  Frontline Science: IL-18 primes murine NK cells for proliferation by promoting protein synthesis, survival, and autophagy.

Authors:  Yosif El-Darawish; Wen Li; Kyosuke Yamanishi; Magdalena Pencheva; Naoto Oka; Hiromichi Yamanishi; Tomohiro Matsuyama; Yoshimasa Tanaka; Nagahiro Minato; Haruki Okamura
Journal:  J Leukoc Biol       Date:  2018-03-30       Impact factor: 4.962

6.  Interleukin-18 mediates interleukin-1-induced cardiac dysfunction.

Authors:  Stefano Toldo; Eleonora Mezzaroma; Laura O'Brien; Carlo Marchetti; Ignacio M Seropian; Norbert F Voelkel; Benjamin W Van Tassell; Charles A Dinarello; Antonio Abbate
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-02-14       Impact factor: 4.733

7.  Host and Environmental Factors Influencing Individual Human Cytokine Responses.

Authors:  Rob Ter Horst; Martin Jaeger; Sanne P Smeekens; Marije Oosting; Morris A Swertz; Yang Li; Vinod Kumar; Dimitri A Diavatopoulos; Anne F M Jansen; Heidi Lemmers; Helga Toenhake-Dijkstra; Antonius E van Herwaarden; Matthijs Janssen; Renate G van der Molen; Irma Joosten; Fred C G J Sweep; Johannes W Smit; Romana T Netea-Maier; Mieke M J F Koenders; Ramnik J Xavier; Jos W M van der Meer; Charles A Dinarello; Norman Pavelka; Cisca Wijmenga; Richard A Notebaart; Leo A B Joosten; Mihai G Netea
Journal:  Cell       Date:  2016-11-03       Impact factor: 41.582

8.  Protection from inflammatory organ damage in a murine model of hemophagocytic lymphohistiocytosis using treatment with IL-18 binding protein.

Authors:  Laura Chiossone; Sandra Audonnet; Bruno Chetaille; Lionel Chasson; Catherine Farnarier; Yael Berda-Haddad; Stefan Jordan; Ulrich H Koszinowski; Marc Dalod; Karin Mazodier; Daniela Novick; Charles A Dinarello; Eric Vivier; Gilles Kaplanski
Journal:  Front Immunol       Date:  2012-08-08       Impact factor: 7.561

Review 9.  Interleukin-18 and IL-18 binding protein.

Authors:  Charles A Dinarello; Daniela Novick; Soohyun Kim; Gilles Kaplanski
Journal:  Front Immunol       Date:  2013-10-08       Impact factor: 7.561

Review 10.  Interleukin-18: Biological properties and role in disease pathogenesis.

Authors:  Gilles Kaplanski
Journal:  Immunol Rev       Date:  2018-01       Impact factor: 12.988
  10 in total
  5 in total

1.  Interleukin-18 and cytotoxic impairment are independent and synergistic causes of murine virus-induced hyperinflammation.

Authors:  Paul Tsoukas; Emily Rapp; Lauren Van Der Kraak; Eric S Weiss; Vinh Dang; Corinne Schneider; Edwin Klein; Jennifer Picarsic; Rosalba Salcedo; C Andrew Stewart; Scott W Canna
Journal:  Blood       Date:  2020-11-05       Impact factor: 22.113

2.  Establishment of interleukin-18 time-resolved fluorescence immunoassay and its preliminary application in liver disease.

Authors:  Li Zhang; Xiumei Zhou; Yaping Dai; Chunyan Lv; Jian Wu; Qingqing Wu; Ting Li; Yigang Wang; Penguo Xia; Hao Pei; Biao Huang
Journal:  J Clin Lab Anal       Date:  2021-03-15       Impact factor: 2.352

Review 3.  Advances in Mast Cell Activation by IL-1 and IL-33 in Sjögren's Syndrome: Promising Inhibitory Effect of IL-37.

Authors:  Pio Conti; Luisa Stellin; Alesssandro Caraffa; Carla E Gallenga; Rhiannon Ross; Spyros K Kritas; Ilias Frydas; Ali Younes; Paolo Di Emidio; Gianpaolo Ronconi
Journal:  Int J Mol Sci       Date:  2020-06-16       Impact factor: 5.923

4.  Evolution Toward Severe Covid-19 From Biological Monitoring to Therapeutic Considerations.

Authors:  Julien Carvelli; Audrey Le Saux; Jeremy Bourenne; Marc Gainnier; Gilles Kaplanski
Journal:  Front Immunol       Date:  2020-12-15       Impact factor: 7.561

Review 5.  To inhibit or to boost the ATP/P2RX7 pathway to fight cancer-that is the question.

Authors:  Serena Janho Dit Hreich; Jonathan Benzaquen; Paul Hofman; Valérie Vouret-Craviari
Journal:  Purinergic Signal       Date:  2021-08-04       Impact factor: 3.765
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.